Inflammation and RONS Dysregulation by Redox Enzymes as Mechanistic Links in HIV-1–Cancer Comorbidity
Pathogens · 14.04.2026 · 15 (4) · 423
DOI: 10.3390/pathogens15040423 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 14.04.2026. Verfasst von Charles Gotuaco Ang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, College of Medicine, Drexel University, Philadelphia, PA 19102, USA. Hauptthemen laut MEDLINE: Neoplasms, HIV Infections, Reactive Oxygen Species, Reactive Nitrogen Species. Die Arbeit nennt 209 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sidney Kimmel Comprehensive Cancer Center, Drexel University College.
Abstract (Originalsprache)
Antiretroviral therapy (ART) effectively controls Human Immunodeficiency Virus Type-1 (HIV-1) infection in people with HIV-1 (PWH), preventing the progression of their infections to AIDS. However, as PWH age, they experience lifestyle- and age-related diseases, notably various types of cancer beyond those traditionally associated with AIDS, with greater incidence and mortality than their non-HIV-1-positive counterparts, despite effective arrest of HIV-1 infection by ART. Dysregulation of redox enzymes presents an underexplored linkage between HIV-1 infection and cancer comorbidity, impacting reactive oxygen/nitrogen species (RONS) management, inflammation, immune function, and mitochondrial function. Chronic HIV-1 infection increases both RONS production and RONS neutralization responses, accelerating development of a sustained RONS-rich environment that still possesses sufficient dampening to prevent outright cytotoxic effects. Such an environment promotes both tumor proliferation and resistance adaptations to chemo- and radiotherapies. This review considers the effects of chronic HIV-1 infection on redox enzyme function and links these effects to tumorigenic mechanisms as potentially shared pathways. We then examine current methods of modulating redox function, consider how these could potentially impact both HIV-1 infection and cancer progression, and lastly propose future methods of co-treatment that could be explored.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, College of Medicine, Drexel University, Philadelphia, PA 19102, USA.
- College of Arts and Sciences, Drexel University, Philadelphia, PA 19104, USA.
ORCID-Profile: Charles Gotuaco Ang, Irwin M Chaiken
Förderung
- Sidney Kimmel Comprehensive Cancer Center
- Drexel University College
Zitieren
APA
Ang, C. G., Eyunni, S., & Chaiken, I. M. (2026). Inflammation and RONS Dysregulation by Redox Enzymes as Mechanistic Links in HIV-1–Cancer Comorbidity. Pathogens, 15(4), 423. https://doi.org/10.3390/pathogens15040423
Vancouver
Ang CG, Eyunni S, Chaiken IM. Inflammation and RONS Dysregulation by Redox Enzymes as Mechanistic Links in HIV-1–Cancer Comorbidity. Pathogens. 2026;15(4):423. doi:10.3390/pathogens15040423
BibTeX
@article{Ang2026,
author = {Ang, Charles Gotuaco and Eyunni, Shreya and Chaiken, Irwin M},
title = {Inflammation and RONS Dysregulation by Redox Enzymes as Mechanistic Links in HIV-1–Cancer Comorbidity},
journal = {Pathogens},
year = {2026},
volume = {15},
number = {4},
pages = {423},
doi = {10.3390/pathogens15040423}
}
EUVIMED